| Riva y García Financial Group | Corporate Finance | Private equity | Private Banking | 
2006 Business transactions
|   
 Date  | 
  
 Client  | 
  
 Transaction  | 
  
 Value  | 
  
 Logo  | 
|   
 05/2006  | 
  
 Astroc  | 
  
 Public offering  | 
  
 Confidential  | 
  
 | 
|   
 07/2006  | 
  
 Natraceutical  | 
  
 Acquisition of 100% of the shares in Forté Pharma  | 
  
 82 million EUROS  | 
  
 
 | 
|   
 07/2006  | 
  
 Mecanotubo  | 
  
 Sale of 51% of capital  | 
  
 Confidential  | 
  
 | 
|   
 10/2006  | 
  
 Natraceutical  | 
  
 Capital increases  | 
  
 61 million EUROS  | 
  
 
 | 
|   
 07/2006  | 
  
 Trader  | 
  
 Sale of 100% of capital to Schibsted  | 
  
 580 million EUROS  | 
  
     
    
    
    
 | 
|   
 
ASTROC 
The role of Riva y García: 
Transaction amount:  | 
  
 
Public offering Flotation 121,190,000 shares RIVA Y GARCÍA acted as the Advisory Company and Placement Agent      
    
    
    
 | 
|   
 
Natraceutical 
The role of Riva y García: 
Transaction amount:  | 
  
 
It has completed the acquisition of 100% of the Forté Pharma shares 82 million Euros RIVA Y GARCÍA acted as the Advisory Company, Lead Manager and Agent      
 | 
|   
 
Mecanotubo Group 
The role of Riva y García: 
Transaction amount:  | 
  
 
Sale of 51% of capital RIVA Y GARCÍA acted as the Advisory Company      
    
    
    
 | 
|   
 
Natraceutical 
The role of Riva y García: 
Transaction amount:  | 
  
   
    
    
    
Capital Increase 61,000 EUROS RIVA Y GARCÍA acted as the Advisory Company, Lead Manager and Agent      
    
    
    
 | 
|   
 
Trader 
The Norwegian group Schibsted has an 80% share in Spain of Multiprensa  
The role of Riva y García: 
Transaction amount:  | 
  
     
    
    
    
Sale of 100% of capital to Schibsted 580,000,000 Euros RIVA Y GARCÍA acted as the Advisory Company      
    
    
    
 | 


